CCM
GILD icon

Cadence Capital Management’s Gilead Sciences GILD Stock Holding History

Cadence Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.02M Sell
32,024
-7,531
-19% -$522K 0.49% 54
2020
Q2 		$3.04M Buy
39,555
+5,059
+15% +$388K 0.44% 43
2020
Q1 		$2.58M Sell
34,496
-400
-1% -$27.6K 0.44% 55
2019
Q4 		$2.27M Buy
34,896
+6,770
+24% +$441K 0.24% 100
2019
Q3 		$1.78M Buy
28,126
+1,124
+4% +$73.5K 0.25% 160
2019
Q2 		$1.82M Buy
27,002
+907
+3% +$59.7K 0.18% 172
2019
Q1 		$1.7M Sell
26,095
-1,248
-5% -$82.9K 0.15% 196
2018
Q4 		$1.71M Sell
27,343
-110,970
-80% -$7.76M 0.17% 180
2018
Q3 		$10.7M Buy
138,313
+5,112
+4% +$386K 0.58% 44
2018
Q2 		$9.44M Buy
133,201
+434
+0.3% +$30.6K 0.56% 46
2018
Q1 		$10M Buy
132,767
+13,517
+11% +$1.07M 0.65% 38
2017
Q4 		$8.54M Sell
119,250
-49,074
-29% -$3.73M 0.54% 51
2017
Q3 		$13.6M Buy
168,324
+11,825
+8% +$904K 0.85% 12
2017
Q2 		$11.1M Sell
156,499
-53,283
-25% -$3.55M 0.77% 29
2017
Q1 		$14.2M Buy
209,782
+19,462
+10% +$1.37M 0.98% 7
2016
Q4 		$13.6M Buy
190,320
+8,891
+5% +$661K 0.95% 11
2016
Q3 		$14.4M Buy
181,429
+142,314
+364% +$11.6M 1.05% 2
2016
Q2 		$3.26M Sell
39,115
-440
-1% -$39K 0.25% 105
2016
Q1 		$3.63M Sell
39,555
-193
-0.5% -$17.4K 0.26% 102
2015
Q4 		$4.02M Sell
39,748
-2,263
-5% -$235K 0.27% 96
2015
Q3 		$4.13M Buy
42,011
+5,665
+16% +$629K 0.29% 97
2015
Q2 		$4.25M Sell
36,346
-397
-1% -$43.4K 0.24% 115
2015
Q1 		$3.61M Sell
36,743
-1,713
-4% -$174K 0.22% 122
2014
Q4 		$3.63M Sell
38,456
-40,074
-51% -$4.14M 0.21% 134
2014
Q3 		$8.36M Sell
78,530
-12,580
-14% -$1.23M 0.44% 69
2014
Q2 		$7.55M Sell
91,110
-8,900
-9% -$693K 0.36% 77
2014
Q1 		$7.09M Buy
+100,010
New +$7.84M 0.3% 95

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cadence Capital Management's GILD Position: Q3 2020 in Review

Cadence Capital Management reduced its Gilead Sciences (GILD) stake by 19% in Q3 2020, selling an estimated $522K and leaving 32,024 shares worth $2.02M. The position accounts for 0.49% of the portfolio, ranked #54.

Cadence Capital Management first reported a position in GILD in Q1 2014 and has held it in 27 quarters since. The position peaked at $14.4M in Q3 2016. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Cadence Capital Management held 32,024 shares of Gilead Sciences worth $2.02M as of Q3 2020.
  • Cadence Capital Management sold 7,531 Gilead Sciences shares in Q3 2020, an estimated $522K.
  • Gilead Sciences made up 0.49% of Cadence Capital Management's portfolio in Q3 2020, its #54 holding.
  • Cadence Capital Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 27 quarters since.
  • Cadence Capital Management's Gilead Sciences position peaked at $14.4M in Q3 2016.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.